REGENXBIO
$47.869876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$47.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.39 (-4.76%) As of 3:13 PM EST today
-$2.39 (-4.76%) Today
Why Robinhood?
You can buy or sell REGENXBIO and other stocks, options, ETFs, and crypto commission-free!
About RGNX
REGENXBIO Inc. Common Stock, also called REGENXBIO, is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Read More The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Employees
192
Headquarters
Rockville, Maryland
Founded
2008
Market Cap
1.98B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
406.94K
High Today
$50.75
Low Today
$47.31
Open Price
$50.56
Volume
396.47K
52 Week High
$63.21
52 Week Low
$30.38
Collections
Analyst Ratings
83%
of 6 ratings
Buy
83%
Hold
17%
Sell
0%
RGNX Earnings
-$0.94
-$0.22
$0.51
$1.23
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.44 per share
Actual
Available Feb 26, After Hours
People Also Bought
Editas Medicine
10,088
$22.68
-4.28%CRISPR
26,944
$50.42
-2.96%Intellia Therapeutics
5,373
$12.12
-3.70%uniQure
671
$55.18
-5.47%Teladoc Health
10,907
$120.25
+5.24%Sangamo Therapeutics
4,943
$6.91
-2.26%bluebird bio
2,101
$73.07
-4.17%Viking Therapeutics
39,286
$6.42
-6.00%Sarepta Therapeutics
2,038
$114.58
-4.18%iQIYI
31,834
$23.97
-0.87%Bristol-Myers Squibb
7,779
$62.11
-2.91%Amarin
16,685